Clinical trial
Combination Antimalarials in Uncomplicated Malaria
NCT00203801 · University of Cape Town, Other · Completed
Key facts
| NCT number | NCT00203801 |
|---|---|
| Title | Combination Antimalarials in Uncomplicated Malaria |
| Official title | Open Label Study to Evaluate Combination Anti-malarial Therapy,in Terms of Efficacy, Prevalence of Gametocyte Carriage and Molecular Markers Associated With Sulfadoxine Pyrimethamine Resistance in Uncomplicated Plasmodium Falciparum |
| Lead sponsor | University of Cape Town, Other |
| Collaborators | World Health Organization Medical Research Council, South Africa Global Fund |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Sulfadoxine-pyrimethamine, Artesunate plus sulfadoxine-pyrimethamine, Artemether-lumefantrine |
| Enrollment | 700 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 19, 2018 |
| Countries | Eswatini, Mozambique, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: